Cerebral Small Vessel Disease: Difference between revisions
No edit summary |
No edit summary |
||
| Line 2: | Line 2: | ||
'''Original Editor '''- [[User:Rahma Ahmed Ahmed Bahbah|Rahma Ahmed Ahmed Bahbah]] | '''Original Editor '''- [[User:Rahma Ahmed Ahmed Bahbah|Rahma Ahmed Ahmed Bahbah]] | ||
'''Top Contributors''' - | '''Top Contributors''' - Rahma Ahmed Ahmed Bahbah | ||
</div> | </div> | ||
| Line 10: | Line 10: | ||
== Introduction == | == Introduction == | ||
== | == Subtypes == | ||
== | == Pathophysiology process == | ||
== | |||
== Management == | |||
Revision as of 02:27, 25 November 2023
Original Editor - Rahma Ahmed Ahmed Bahbah
Top Contributors - Rahma Ahmed Ahmed Bahbah
This article or area is currently under construction and may only be partially complete. Please come back soon to see the finished work! (25/11/2023)
Introduction[edit | edit source]
Subtypes[edit | edit source]
Pathophysiology process[edit | edit source]
Management[edit | edit source]
References[edit | edit source]
- Antoine M. Hakim , Small Vessel Disease , Volume 10 - 2019 | Frontiers, https://doi.org/10.3389/fneur.2019.01020
- Amita Singh, Gabriel Bonnell, Justin De Prey, Natalie Buchwald, Kyrillos Eskander, Keith J. Kincaid, Christina A. Wilson, Small-vessel disease in the brain ,American Heart Journal Plus: Cardiology Research and Practice https://doi.org/10.1016/j.ahjo.2023.100277.
